CEFOTAXIME is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Cefotaxime Sodium.
| Product ID | 68180-811_b5024702-310b-4170-a820-86ba597c4894 |
| NDC | 68180-811 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CEFOTAXIME |
| Generic Name | Cefotaxime |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2005-05-27 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065124 |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | CEFOTAXIME SODIUM |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2005-05-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA065124 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2005-05-27 |
| Marketing End Date | 2018-01-25 |
| Ingredient | Strength |
|---|---|
| CEFOTAXIME SODIUM | 500 mg/1 |
| SPL SET ID: | 4ebb9704-6b9f-4b47-aac4-d54fe34f0b83 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9930 | Cefotaxime | Cefotaxime |
| 0143-9931 | Cefotaxime | Cefotaxime |
| 0143-9933 | Cefotaxime | Cefotaxime |
| 0143-9935 | Cefotaxime | Cefotaxime |
| 21586-011 | Cefotaxime | cefotaxime injection |
| 21586-012 | Cefotaxime | cefotaxime injection |
| 55648-947 | CEFOTAXIME | CEFOTAXIME |
| 55648-948 | CEFOTAXIME | CEFOTAXIME |
| 55648-986 | CEFOTAXIME | CEFOTAXIME |
| 64679-947 | Cefotaxime | Cefotaxime |
| 64679-948 | Cefotaxime | Cefotaxime |
| 64679-986 | Cefotaxime | Cefotaxime |
| 68180-811 | CEFOTAXIME | CEFOTAXIME |
| 68180-822 | CEFOTAXIME | CEFOTAXIME |
| 68180-833 | CEFOTAXIME | CEFOTAXIME |